S.296
An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Sponsors:
Sen. Cheryl Hooker
,
Sen. Rebecca Balint, Sen. Alison Clarkson, Sen. Ruth Hardy, Sen. Deborah Ingram, Sen. Richard McCormack, Sen. Alice Nitka, Sen. Richard Sears
Location: House Committee on Health Care
Last Recorded Action: 3/13/2020 - Referred to the Committee on Health Care
Committee Activity - Witnesses Who Testified
Regular Session 2019-2020
Senate Committee on Finance
- Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- Michael Fisher, Chief Health Care Advocate, Office of the Health Care Advocate, Vermont Legal Aid
- Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
- Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
- Stephen Habbe, Director State Government Affairs, American Diabetes Association
- Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
- Margaret Laggis, Lobbyist, America's Health Insurance Plans
- Elia Spates Marquis, Newport
- Brian Murphy, Director of Pharmacy and Vendor Management, Blue Cross Blue Shield of Vermont
- Kevin O'Hara, Williston, Vermont
- Saumya Saini, Vermont Medical Society
- Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont